Stocksigma LogoStocksigma Logo

OneSource Specialty Pharma Schedules Board Meeting for Q2 FY27 Results

OneSource Specialty Pharma Limited announced that its Board of Directors will meet on 27th Oct'26 to consider and approve the unaudited standalone and

OneSource Specialty Pharma Schedules Board Meeting for Q2 FY27 Results

Onesource Specialty Pharma Ltd 路 Intimation 路 27 Oct 2026, 5:30 am

OneSource Specialty Pharma Schedules Board Meeting for Q2 FY27 Results OneSource Specialty Pharma Limited announced that its Board of Directors will meet on 27th Oct'26 to consider and approve the unaudited standalone and consolidated financial results for the quarter ended 30th Sep'26. In compliance with insider trading regulations, the trading window for designated persons has been closed since 1st Oct'26 and will reopen 48 hours following the public dissemination of the financial results.

Original exchange filing (PDF)

More announcements from Onesource Specialty Pharma Ltd

All Onesource Specialty Pharma Ltd announcements